<?xml version="1.0" encoding="utf-8" ?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
	<channel>
		<title>Pharmalicensing.com: PR Newswire</title>
		<link>http://pharmalicensing.com/rss/</link>
		<description>Latest market and business intelligence from the leading publishers worldwide.</description>
		<language>en-us</language>
		<image>
			<title>Pharmalicensing.com: PR Newswire</title>
			<link>http://pharmalicensing.com/rss/</link>
			<url>http://pharmalicensing.com/images/pharmalicensing_logo.gif</url>
			<width>144</width>
		</image>
									<item>
				<title>Cervical Cancer Charity Welcomes Department of Health&#039;s Announcement About HPV Vaccine</title>
				<description>LONDON, June 18 /PRNewswire/ -- The UK&#039;s leading cervical cancer charity, Jo&#039;s Trust, has today welcomed
the Department of Health&#039;s announcement that the HPV vaccine, Cervarix will
be used in the...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1241</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1241</guid>
				<pubDate>Wed, 18 Jun 2008 15:38:00 +0000</pubDate>
			</item>
					<item>
				<title>Reliant Technologies Announces World Premiere of Fraxel re:pair(TM) Laser: A New Class of Treatment Therapy for CO2 Laser Skin Resurfacing in the EMEA</title>
				<description>PARIS, April 10 /PRNewswire/ -- Reliant Technologies, Inc., the pioneer of fractional resurfacing and
market leader of aesthetic laser skin treatments, today announced its
European launch of the...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/761</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/761</guid>
				<pubDate>Thu, 10 Apr 2008 08:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Movetis Files RESOLOR(R) With EMEA for the Indication of Chronic Constipation</title>
				<description>TURNHOUT, Belgium, May 29 /PRNewswire/ -- Movetis today announced that the European Medicines Agency (EMeA) has
accepted the Marketing Authorization Application (MAA) submission for
RESOLOR(R)...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1097</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1097</guid>
				<pubDate>Thu, 29 May 2008 17:22:00 +0000</pubDate>
			</item>
					<item>
				<title>Wyeth and Progenics Receive Positive Opinion From European  Committee for RELISTOR for the Treatment of Opioid-Induced Constipation in Advanced-Illness Patients</title>
				<description>COLLEGEVILLE, Pennsylvania and TARRYTOWN, New York, April 24 /PRNewswire/ -- Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), and Progenics
Pharmaceuticals, Inc. (Nasdaq: PGNX), today...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/862</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/862</guid>
				<pubDate>Thu, 24 Apr 2008 20:52:00 +0000</pubDate>
			</item>
					<item>
				<title>NHS Ancillary and Ambulance Staff Overwhelmingly Reject the Government&#039;s Three Year Pay Deal</title>
				<description>LONDON, May 19 /PRNewswire/ -- Unite the Union members working in the NHS as ancillary and ambulance
staff, have overwhelmingly rejected the Government&#039;s 7.99% three year pay
deal.

    In a ballot...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1031</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1031</guid>
				<pubDate>Mon, 19 May 2008 13:36:00 +0000</pubDate>
			</item>
						<atom:link href="http://pharmalicensing.com/public/public/news/mostviewedrss/249/European_Government" rel="self" type="application/rss+xml" />
	</channel>
</rss>
